Inhibrx Biosciences Inc (INBX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2017 | 12-2006 | |
| Sales | 13,211 | 0 | 0 |
| Gross Profit | 13,211 | N/A | N/A |
| Operating Expenses | 56,925 | 0 | 0 |
| Operating Income | -43,714 | N/A | N/A |
| Interest Expense | 5,719 | 0 | 0 |
| Other Income | -1,069 | 0 | 0 |
| Pre-tax Income | -50,502 | 0 | 0 |
| Income Tax | 898 | N/A | N/A |
| Net Income Continuous | -51,400 | N/A | N/A |
| Net Income | $-51,400 | $N/A | $N/A |
| EPS Basic Total Ops | -2.83 | N/A | N/A |
| EPS Basic Continuous Ops | -2.83 | N/A | N/A |
| EPS Diluted Total Ops | -2.83 | N/A | N/A |
| EPS Diluted Continuous Ops | -2.83 | N/A | N/A |
| EBITDA(a) | $-37,053 | $N/A | $N/A |